Robbie Huffines, the global chairman of investment banking at JPMorgan Chase & Co. (NYSE:JPM) who retired in Q1 2022, has announced plans to launch a non-profit organization. The initiative aims to address children's mental health in disadvantaged communities.
Huffines began his career at JPMorgan in 1991 within the mergers and acquisitions group, where he honed his expertise in healthcare transactions. From 2002 to 2010, he served as the global co-head of healthcare investment banking before being promoted to vice chairman.
His tenure at JPMorgan is marked by several landmark deals. Notably, he played a key role in Johnson & Johnson (NYSE:JNJ)'s takeover of Abiomed (NASDAQ:ABMD) and orchestrated Celgene (NASDAQ:CELG)'s $74 billion sale to Bristol Myers (NYSE:BMY) Squibb.
The move to the non-profit sector represents a significant shift for Huffines, who has spent over three decades in the financial industry. His extensive experience and knowledge of healthcare transactions are expected to be instrumental in his new role.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.